In 2025, over 200 companies had their initial public offerings (IPOs) on U.S. exchanges. However, less than a quarter of ...

From Wall Street to Silicon Valley, attention is building around a rare convergence of potential blockbuster listings ...

The San Francisco-based company had previously filed confidentially and is now moving ahead with a public disclosure of its ...

Evommune filed for a US$100m NYSE IPO on Thursday afternoon to help fund advanced trials for its two promising treatments for autoimmune diseases. Despite the ongoing US government shutdown, the ...

Medtronic‘s (NYSE: MDT) diabetes unit, MiniMed Group, filed for a U.S. initial public offering (IPO) on Friday, as part of its separation from the medical devices maker. The Northridge, ...

After a long-winded exodus, London’s flagship stock exchange saw a flurry of IPO activity at the tail end of last year, with ...

The New York Stock Exchange, part of Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, today announced it listed seven of the 10 largest IPOs of the year ...

Stocks hold steady Tuesday morning after the S&P 500's tech-driven rally on Monday, which saw Alphabet jump over 6% on optimism around its Gemini AI model; Meta is reportedly in talks to use Google ...

Good morning. Similar to the volatility observed in April, market uncertainty increased in October amid renewed concerns over a potential flare-up in the U.S.–China trade war. Lynn Martin, president ...

Evommune (EVMN), a biotechnology startup, has set the price for its initial public offering at $16 per share for approximately 9.4M shares. Trading is anticipated to commence on the New York Stock ...

In 2024, medtech IPOs began to come back, thanks to the likes of heart valve company Anteris Technologies and neurotech ...